Diversified Portfolio

UPDATED ON

Sep 25

About this portfolio

Description

Diversified holds up to 5 names from all sectors above $500M, with no more than one per industry at any time. Selection follows the model's volatility score.

Strategy

Equal capital goes into every recommendation. Recommendations are published a few hours before the open and placed as market orders, so buys and sells fill at the opening price. Positions are held for 6 to 21 days. Every position carries a 20% stop-loss: if the price touches it during the day, the position is sold there, at 80% of its entry price. Reported returns are measured from those opening prices and include every stop-loss exit.

Holdings:5
New Additions:0
Removed:0

Holdings5

OABI

OmniAb, Inc.
Sector:Healthcare
Industry:Biotechnology
Market Cap:$0.65B
Analysts Target:-10%
Analysts Rating:2.0/5
ForecastQ Daily Probabilities
53.9%
50.6%
43.6%

ASST

Strive, Inc.
Sector:Financial Services
Industry:Asset Management
Market Cap:$3.01B
Analysts Target:+10%
Analysts Rating:2.0/5
ForecastQ Daily Probabilities
46.9%
69.7%
61.0%

WGS

GeneDx Holdings Corp.
Sector:Healthcare
Industry:Medical - Diagnostics & Research
Market Cap:$3.02B
Analysts Target:-21%
Analysts Rating:2.1/5
ForecastQ Daily Probabilities
53.9%
50.5%
45.3%

NTSK

Netskope, Inc. Class A Common Stock
Sector:Technology
Industry:Software - Infrastructure
Market Cap:$7.07B
Analysts Target:+4%
Analysts Rating:2.0/5
ForecastQ Daily Probabilities
42.3%
81.8%
41.1%

VIA

Via Transportation, Inc.
Sector:Technology
Industry:Software - Application
Market Cap:$2.17B
Analysts Target:+7%
Analysts Rating:2.0/5
ForecastQ Daily Probabilities
43.2%
68.4%
36.7%

Recent News & Events

OABIPOSITIVEOct 6, 2026
Investor Conference

OmniAb Investor & Analyst Day

OmniAb will host an Investor & Analyst Day at its headquarters in Emeryville, California. The event will feature presentations from the executive leadership team covering corporate updates, partner programs, the xPloration platform, and technology innovations, followed by a Q&A session and laboratory tours.

Business Wire
WGSNEGATIVESep 23, 2026
Regulatory Filing

Proposed 2027 Medicare Lab Rate Cuts

Investors are reacting to a proposed 2027 Medicare lab rate update that could reduce reimbursement by up to 15% for several key tests. This potential regulatory change threatens future revenue and margins, contributing to recent stock price volatility and downward pressure.

TipRanks
ASSTPOSITIVESep 22, 2026
Analyst Upgrade

B. Riley Raises Strive Price Target to $33

B. Riley Securities increased its price target for Strive from $26 to $33 while maintaining a Buy rating. This analyst action reflects growing institutional confidence in the company's Bitcoin treasury model and its positioning as a beneficiary of potential regulatory shifts.

MarketBeat
ASSTPOSITIVESep 18, 2026
Corporate Filing

Disclosure of Additional Bitcoin Purchase

Strive disclosed the purchase of 1,355 Bitcoin for approximately $107.7 million, bringing its total treasury holdings to 26,355 BTC. This ongoing accumulation strategy is a primary driver of the stock's performance and market narrative as a high-beta Bitcoin proxy.

Strive.com
ASSTPOSITIVESep 18, 2026
Product Launch

Launch of 2x Leveraged ETF (ASSX)

REX Shares and Tuttle Capital launched the ASSX ETF, which provides 2x leveraged exposure to Strive's daily performance. The introduction of this financial product has increased trading interest and volatility in ASST shares by deepening market exposure.

Business Wire

ForecastQ

Quantitative stocks signals powered by AI


The information provided is for educational purposes only and should not be considered financial advice. Past performance is not indicative of future results. ForecastQ is a research platform, a living documentation of an engineering experiment. We are not financial advisors.


© ForecastQ. All rights reserved.